Zimmer Biomet Financials

ZBH Stock  USD 132.65  0.04  0.03%   
Based on the key indicators related to Zimmer Biomet's liquidity, profitability, solvency, and operating efficiency, Zimmer Biomet Holdings may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. As of now, Zimmer Biomet's Other Assets are increasing as compared to previous years. The Zimmer Biomet's current Cash is estimated to increase to about 591.2 M, while Common Stock Shares Outstanding is projected to decrease to under 164.9 M. Key indicators impacting Zimmer Biomet's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.670.4664
Way Up
Slightly volatile
Operating Income857.6 M1.4 B
Way Down
Pretty Stable
Current Ratio2.851.6132
Way Up
Slightly volatile
The financial analysis of Zimmer Biomet is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Zimmer Biomet includes many different criteria found on its balance sheet. For example, investors should never minimize Zimmer Biomet's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Zimmer Biomet's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Zimmer Biomet.

Cash And Equivalents

454.34 Million

With this module, you can analyze Zimmer financials for your investing period. You should be able to track the changes in Zimmer Biomet individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Zimmer Biomet Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Zimmer Biomet's financial statements are interrelated, with each one affecting the others. For example, an increase in Zimmer Biomet's assets may result in an increase in income on the income statement.
Evaluating Zimmer Biomet's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of Zimmer Biomet's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the Zimmer Biomet's relative financial performance

Chance Of Distress

Less than 6

 
100  
 
Zero
Low
Zimmer Biomet Holdings has less than 6 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Zimmer Biomet stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, Zimmer Biomet's odds of distress score SHOULD NOT be confused with the real chance of Zimmer Biomet Holdings filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as Zimmer is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include Zimmer Biomet's liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in Zimmer Biomet's official financial statements usually reflect Zimmer Biomet's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Zimmer Biomet Holdings. For example, before you start analyzing numbers published by Zimmer accountants, it's critical to develop an understanding of what Zimmer Biomet's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Zimmer Biomet's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zimmer Biomet's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Zimmer Biomet's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Zimmer Biomet Holdings. Please utilize our Beneish M Score to check the likelihood of Zimmer Biomet's management manipulating its earnings.

Zimmer Biomet Company Summary

Zimmer Biomet competes with Cigna Corp, Definitive Healthcare, Guardant Health, Laboratory, and Mednax. Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. Zimmer Biomet operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 19500 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
CIK Number0001136869
ISINUS98956P1021
CUSIP98956P102
RegionNorth America
LocationIndiana; U.S.A
Business Address345 East Main
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkNYSE Composite
Websitewww.zimmerbiomet.com
Phone574 373 3333
CurrencyUSD - US Dollar
You should never invest in Zimmer Biomet without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Zimmer Stock, because this is throwing your money away. Analyzing the key information contained in Zimmer Biomet's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Zimmer Biomet Key Financial Ratios

Generally speaking, Zimmer Biomet's financial ratios allow both analysts and investors to convert raw data from Zimmer Biomet's financial statements into concise, actionable information that can be used to evaluate the performance of Zimmer Biomet over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Zimmer Biomet Holdings reports annually and quarterly.

Zimmer Biomet Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets24.6B24.4B23.5B21.1B21.5B13.7B
Other Current Liab1.9B1.6B511M985M1.3B941.7M
Accounts Payable400.9M330M306.5M354.1M379.8M228.6M
Net Receivables1.4B1.5B1.3B1.4B1.4B975.8M
Inventory2.4B2.5B2.1B2.1B2.4B1.4B
Other Current Assets357.1M377.8M607.1M522.9M366.1M363.9M
Total Liab12.2B12.2B10.8B9.0B9.0B6.3B
Total Current Assets4.7B5.1B4.9B4.4B4.6B3.4B
Other Liab1.9B2.0B1.9B1.1B1.3B1.2B
Other Assets652.9M969.4M1.1B1.1B1.3B1.4B
Net Debt7.6B7.3B6.7B5.3B5.6B3.7B
Retained Earnings10.4B10.1B10.3B9.6B10.4B6.8B
Cash617.9M802.1M378.1M375.7M415.8M591.2M
Long Term Debt6.7B7.6B5.5B5.2B5.0B4.0B
Good Will9.6B9.3B8.9B8.6B8.8B6.0B
Intangible Assets7.3B7.1B5.5B5.1B4.9B4.2B
Treasury Stock(6.7B)(6.7B)(6.7B)(6.9B)(6.2B)(6.5B)
Net Tangible Assets(4.5B)(4.1B)(2.8B)(1.6B)(1.5B)(1.5B)
Capital Surpluse8.9B9.1B9.3B9.5B10.9B7.5B

Zimmer Biomet Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what Zimmer Biomet's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
201920202021202220232024 (projected)
Interest Expense226.9M212M208.4M164.8M195.3M141.2M
Total Revenue8.0B7.0B6.8B6.9B7.4B5.0B
Gross Profit5.7B4.9B4.9B4.9B4.7B3.6B
Operating Income1.1B723.3M860.3M1.1B1.4B857.6M
Ebit1.1B723.3M860.3M1.1B1.4B1.1B
Research Development449.3M372M435.8M406M458.7M259.0M
Ebitda2.3B1.8B2.0B2.0B2.3B1.6B
Cost Of Revenue2.3B2.1B2.0B2.0B2.7B1.4B
Income Before Tax905.8M(274.4M)499M403.5M1.1B1.1B
Net Income1.1B(137.4M)401.6M231.4M1.0B580.9M
Income Tax Expense(225.7M)(137M)53.5M112.3M42.2M66.9M
Extraordinary Items315M5M(30.1M)(58.8M)(52.9M)(50.3M)
Non Recurring70.1M645M16.3M292.8M336.7M410.1M
Tax Provision(225.7M)(137M)16.3M112.3M232.8M244.4M
Interest Income237.9M212M208.4M164.8M189.5M148.5M
Net Interest Income(226.9M)(212M)(208.4M)(164.8M)(193.5M)(203.2M)

Zimmer Biomet Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Zimmer Biomet Holdings. It measures of how well Zimmer is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Zimmer Biomet brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Zimmer had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Zimmer Biomet has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
201920202021202220232024 (projected)
Free Cash Flow1.2B1.1B1.3B1.1B892.4M899.3M
Depreciation1.0B1.0B937.7M926.4M951.7M514.0M
Capital Expenditures404.7M117.9M152M187.9M689.2M723.7M
Net Income1.1B(137.4M)445.5M291.2M1.0B585.0M
End Period Cash Flow617.9M802.1M478.5M375.7M415.8M596.1M
Other Non Cash Items608.8M633M276.3M337.9M(1.4M)(1.3M)
Change To Inventory(125.2M)(40.8M)(8.4M)(75.6M)(240.4M)(228.4M)
Change In Cash75.1M184.2M(323.6M)(102.8M)40.1M42.1M
Change To Netincome(384.3M)736.7M267.2M378.5M435.3M457.0M
Dividends Paid196.7M198.5M200.1M201.2M(200.9M)(190.9M)
Investments48.1M53.5M(503.6M)(529.2M)(670.6M)(637.1M)
Change Receivables(93.8M)(70M)(15.1M)(184.7M)(166.2M)(157.9M)
Net Borrowings(716.1M)(275.2M)(1.1B)(1.1B)(956.1M)(908.3M)

Zimmer Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Zimmer Biomet's current stock value. Our valuation model uses many indicators to compare Zimmer Biomet value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zimmer Biomet competition to find correlations between indicators driving Zimmer Biomet's intrinsic value. More Info.
Zimmer Biomet Holdings is rated second in current asset category among related companies. It is rated second in shares outstanding category among related companies creating about  0.04  of Shares Outstanding per Current Asset. The ratio of Current Asset to Shares Outstanding for Zimmer Biomet Holdings is roughly  28.54 . The current Common Stock Shares Outstanding is estimated to decrease to about 164.9 M. Comparative valuation analysis is a catch-all model that can be used if you cannot value Zimmer Biomet by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Zimmer Biomet's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zimmer Biomet's earnings, one of the primary drivers of an investment's value.

Zimmer Biomet Holdings Systematic Risk

Zimmer Biomet's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Zimmer Biomet volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Zimmer Biomet Holdings correlated with the market. If Beta is less than 0 Zimmer Biomet generally moves in the opposite direction as compared to the market. If Zimmer Biomet Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Zimmer Biomet Holdings is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Zimmer Biomet is generally in the same direction as the market. If Beta > 1 Zimmer Biomet moves generally in the same direction as, but more than the movement of the benchmark.

About Zimmer Biomet Financials

What exactly are Zimmer Biomet Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Zimmer Biomet's income statement, its balance sheet, and the statement of cash flows. Potential Zimmer Biomet investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Zimmer Biomet investors may use each financial statement separately, they are all related. The changes in Zimmer Biomet's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Zimmer Biomet's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze Zimmer Biomet Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Zimmer Biomet is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Zimmer has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Zimmer Biomet's financials are consistent with your investment objective using the following steps:
  • Review Zimmer Biomet's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Zimmer Biomet's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Zimmer Biomet's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Zimmer Biomet's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Zimmer Biomet Thematic Clasifications

Zimmer Biomet Holdings is part of Obamacare Repeal investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal
Obamacare RepealView
This theme covers Large healthcare related equities associated with Obamacare. Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal. Get More Thematic Ideas
Today, most investors in Zimmer Biomet Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Zimmer Biomet's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Zimmer Biomet growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0935

As of now, Zimmer Biomet's Price Earnings To Growth Ratio is decreasing as compared to previous years.

Zimmer Biomet March 28, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Zimmer Biomet help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Zimmer Biomet Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zimmer Biomet Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Zimmer Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zimmer Biomet's daily price indicators and compare them against related drivers.
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Zimmer Biomet Holdings information on this page should be used as a complementary analysis to other Zimmer Biomet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Zimmer Stock analysis

When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Zimmer Biomet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.16)
Dividend Share
0.96
Earnings Share
4.88
Revenue Per Share
35.43
Quarterly Revenue Growth
0.063
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.